MDR Makes EU ‘Much Less Attractive’ For Start-Ups, Says Medtronic EMEA Chief
The fragility of start-ups belies their value in medtech innovation, and they do not need unnecessary regulatory complications.
You may also be interested in...
Health warning to global medtechs: The world’s largest medical device company is taking steps to strengthen key account management, retain its market share hold and set up new health care partnerships.
Sir Simon Stevens leaves his position as chief executive of NHS England at the end of July after seven years of probably unmatched achievement. His will be big shoes to fill by Amanda Pritchard, his erstwhile deputy.
On this week’s podcast we highlight US Medicare reimbursement topics that industry should keep an eye on, and discuss important regulatory changes underway in the UK.